Reducing the transmission of HIV-1: Needle bleaching as a means of disinfection

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)

Volumn 40, Issue 6, 2000, Pages 812-817

  Romanelli, Frank ^a   Smith, Kelly M ^a   Pomeroy, Claire ^b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHLORITE SODIUM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; DISINFECTION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NEEDLE; PHARMACIST; REVIEW; SUBSTANCE ABUSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISINFECTION; HIV SEROPREVALENCE; HIV-1; HUMANS; NEEDLES; PHARMACISTS; SODIUM HYPOCHLORITE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0034332236     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1086-5802(16)31128-7     Document Type: Review

References (46)

1. Update: trends in AIDS incidence—United States, 1996 MMWR 46 1997 861 867
2. Centers for Disease Control and Prevention. National HIV Prevalence Surveys, 1997 Summary 1998 Centers for Disease Control and Prevention Atlanta, Ga 1-25
3. Centers for Disease Control and Prevention National HIV Prevalence Surveys, 1999 Midyear Edition 1999 Centers for Disease Control and Prevention Atlanta, Ga 1-42
4. J. Normand D. Vlahov L.E. Mosses Preventing HIV Transmission: The Role of Sterile Needles and Bleach 1995 National Academy Press Washington, DC
5. Needle exchange programs: research suggests promise as an AIDS prevention strategy. Report to the Chairman, Select Committee on Narcotics Abuse and Control 1993 US House of Representatives Washington, DC GPO publication GA1.13:HRD-93-60
6. C.B. McCoy P. Shapshak L.R. Metsch HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols Archivum Immunologiae et Therapiae Experimentalis. 43 1995 1 9
7. A. Watson Needle exchange and access to sterile syringes. Issue Brief. StateServ Web site 2000 Available at: www.statesserv.hpts.org Accessed August 30, 2000
8. National groups seek better access to sterile syringes [press release] 1999 American Medical Association, American Pharmaceutical Association, Association of State and Territorial Health Officials, National Alliance of State and Territorial Aids Directors Chicago, Ill October
9. P. Lurie A.I. Reginold B. Bowser The public health impact of needle exchange programs in the United States and abroad, vol. 1 1993 Centers for Disease Control and Prevention Atlanta, Ga: September
10. D.C. Des Jarlis S.R. Friedman AIDS and legal access to sterile drug injection equipment Ann Am Acad Political Soc Sci. 521 1992 42 65
11. D.C. Des Jarlis Current Findings in Syringe Exchange Research 1994 UK Department of Public Health London, England
12. G.V. Stimson Syringe-exchange programs for injecting drug users AIDS. 3 1989 253 260
13. Y. Obadia I. Feroni V. Perrin Syringe vending machines for injection drug users: an experiment in Marseille, France Am J Public Health. 89 1999 1852 1854
14. Centers for Disease Control and Prevention Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs MMWR. 31 1982 577 580
15. B. Spire F. Barre-Sinoussi L. Montagnier Inactivation of lymphadenopathy associated virus by chemical disinfectants Lancet. 2 1984 899 900
16. L.S. Martin J.S. McDougal S.L. Loskoski Disinfection and inactivation of the human T Iymphotrophic virus type III/lymphadenopathy-associated virus J Infect Dis. 152 1985 400 403
17. L. Resnick K. Veren S.Z. Salahudddin Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments JAMA. 255 1986 1887 1891
18. N. Abdala P.C. Stephens B.P. Griffith Survival of HIV-1 in syringes J Acquir Immune Defic Syndr. 20 1999 73 80
19. D.D. Chitwood C.B. McCoy J.A. Inciardi HIV-1 seropositivity of needles from shooting galieries in South Florida Am J Public Health. 80 1990 150 152
20. J. Wolk A. Wodak A. Morlet Syringe HIV-1 seroprevalence and behavioral and demographic characteristics of intravenous drug users in Sydney, Australia AIDS. 2 1987 373 377
21. R. Heimer S.S. Myers E.C. Cadman Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users J Infect Dis. 165 1992 781 782
22. J.A. Newmeyer Why bleach? Fighting AIDS contagion among intravenous drug users in the community: street based education and risk behavior Am J Commun Psychol. 18 1990 587 596
23. J.K. Watters Historical perspective on the use of bleach in HIV/AIDS prevention J Acquir Immune Defic Syndr. 7 1994 743 746
24. R.E. Chaisson D. Osmond A.R. Moss HIV, bleach and needle sharing Lancet. 2 1987 1430
25. United States Public Health Service Healthy People 2000 1991 US Dept of Health and Human Services Washington, DC Publication PHS 91-50212
26. Centers for Disease Control and Prevention Use of bleach for disinfection of drug injection equipment MMWR 42 1993 418 419
27. CDC, HRSA, NIDA, SAMSHA HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs 1997 US Dept Health and Human Services Washington, DC May 9
28. CDC, NIDA, AMA, APhA HIV Prevention Bulletin: HIV Prevention and Access to Sterile Syringes 1999 US Dept Health and Human Services Washington, DC October
29. P. Shapshak C.B. McCoy S.M. Shah Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach J Acquir Immune Defic Syndr. 7 1994 754 759
30. R. Floyd HIV-1 inactivation by bleach [letter] J Acquir Immune Defic Syndr. 7 1994 204 210
31. J. Newmeyer L. Drew R. Miner HIV transmission in simulated conditions of sharing of hypodermic equipment [letter] J Acquir Immune Defic Syndr. 3 1990 1019 1021
32. J.D. Druce S.A. Locarnini C.J. Birch Syringe cleaning techniques and transmission of HIV AIDS. 9 1995 1105 1106
33. A.A. Aranda D. Viza R.A. Busnel Chemical inactivation of human immunodeficiency virus in vitro J Viral Methods. 37 1992 71 82
34. J.E. Siegel M.C. Weinstein H.V. Fineberg Bleach programs for preventing AIDS among IV drug users: modeling the impact of HIV prevalence Am J Public Health. 81 1991 1273 1279
35. D. Vlahov A. Munoz C.J. Anthony HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland Epidemiology. 132 1990 847 856
36. D. Vlahov J. Astemborski L. Solomon Field effectiveness of needle disinfection among injecting drug users J Acquir Immune Defic Syndr. 7 1994 760 766
37. S. Titus M. Marmor D.D. Jarlis Bleach use and HIV seroconversion among New York City injection drug users J Acquir Immune Defic Syndr. 7 1994 700 704
38. N. Flynn S. Jain E.M. Keddie In vitro activity of readily available household materials against HIV-1: is bleach enough? J Acquir Immune Defic Syndr. 7 1994 747 753
39. D.L. Morgan Intravenous injection of household bleach Ann Int Med. 21 1992 1394 1395
40. A.A. Gleghorn M.C. Doherty D.D. Vlahov Inadequate bleach contact times during syringe cleansing among injection drug users J Acquir Immune Defic Syndr. 7 1994 762 772
41. C.B. McCoy J.E. Rivers H.V. McCoy Compliance to bleach disinfection protocols among injecting drug users in Miami J Acquir Immune Defic Syndr. 7 1994 773 776
42. F. Rhodes N.H. Corby R.J. Wolitski Risk behaviors and perceptions of AIDS among street injection drug users J Drug Edu. 20 1990 271 288
43. P. Lurie S.T. Jones J. Foley A sterile syringe for every drug user injection: how many injections take place annualiy and how might pharmacists contribute to syringe distribution J Acquir Immune Defic Syndr. 18 1998 S4S S51
44. A. Neaigus M. Sufian S.R. Friedman Effects of outreach intervention on risk reduction among intravenous drug users AIDS Edu Prev. 2 1990 253 271
45. A.R. Moss R. Chaisson AIDS and intravenous drug use in San Francisco AIDS. 3 1988 37 41
46. G.E. Macalino K.W. Springer Z.S. Rahman Community-based programs for safe disposal of used needles and syringes J Acquir Immune Defic Syndr. 18S 1998 S111 S119